FDA Approved: GIVLAARI — Original Application (Alnylam Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved GIVLAARI (givosiran) in an Original Application for the treatment of acute hepatic porphyria, marking the drug's initial approval for this cond…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Porphyria

Drugs mentioned

• GIVLAARI (Givosiran)

Snippet

ORIG AP for GIVLAARI (GIVOSIRAN SODIUM)